Four promoters of Vineet Laboratories Limited have significantly reduced their stakes in the company through on-market sales on September 1, 2025. The transactions, totaling ₹53.2 lakh, were conducted on the National Stock Exchange (NSE).

Details of the Share Sales

Regulatory Compliance

The company has duly informed the stock exchanges about these transactions in compliance with Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. The disclosure was made through Form C, which was enclosed with the company's letter to the stock exchanges.

Impact on Shareholding

These sales have resulted in a cumulative reduction of promoter shareholding in Vineet Laboratories Limited. The largest sale in terms of volume and value was made by Gaddam Venkata Ramana, who offloaded 80,000 shares.

Company Background

Vineet Laboratories Limited, with its registered office in Hyderabad, Telangana, is engaged in the pharmaceutical sector. The company's shares are listed on both the BSE and NSE.

Vineet Laboratories Limited , a pharmaceutical company, has reported significant changes in its promoter shareholdings through two separate transactions.

Mrs. Gaddam Venkata Rama's Transaction

Mrs. Gaddam Venkata Rama, a promoter of the company, executed a sale of 1,50,000 equity shares through the National Stock Exchange (NSE). The transaction was valued at ₹50.10 lakh, implying an average price of approximately ₹33.40 per share.

Impact on Shareholding

The sale has resulted in a notable reduction in Mrs. Gaddam's stake in the company:

This transaction represents a decrease of 1.63 percentage points in Mrs. Gaddam's ownership of the company.

Mr. Satyanarayana Raju Bhupathiraju's Transaction

In a separate transaction, Mr. Satyanarayana Raju Bhupathiraju, another promoter, sold 56,164 equity shares. Following the sale, his shareholding decreased from 406,452 shares (3.50%) to 350,288 shares (3.02%).

Regulatory Compliance

Both sales were conducted on the open market and have been disclosed in accordance with the Securities and Exchange Board of India (SEBI) Insider Trading Regulations. Vineet Laboratories Limited has duly informed the stock exchanges about these transactions, as required by Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Company Response

Ramesh Kumar Bandari, the Company Secretary and Compliance Officer of Vineet Laboratories Limited, has confirmed the receipt of the intimations from both promoters regarding their respective share sales. The company has promptly disclosed this information to both the BSE Limited and the National Stock Exchange of India Limited.

Investors and market participants are advised to take note of these changes in the promoter shareholding pattern of Vineet Laboratories Limited. Such transactions often attract attention as they may influence market sentiment and perceptions about the company's future prospects.